Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
86.01
+4.66 (5.73%)
At close: Oct 9, 2026, 4:00 PM EDT
84.50
-1.51 (-1.76%)
After-hours: Oct 9, 2026, 7:41 PM EDT
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $5.58 billion as of October 9, 2026. It is the 3,363rd most valuable company in the world and the 1,069th biggest in the United States. Its market cap has increased by 52.60% in one year.
Market Cap
5.58B
Enterprise Value
5.91B
1-Year Change
52.60%
Global Rank
Country Rank
#1,069 United States
Category
ChartMarket Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $5.58B, an increase of 1,778.97%. That is a compound annual growth rate of 50.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 5.58B | 36.80% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 5.91B |
| Ligand Pharmaceuticals | 5.88B |
| CG Oncology | 5.61B |
| Erasca | 5.41B |
| Veradermics | 5.29B |
| PTC Therapeutics | 5.22B |
| Cogent Biosciences | 5.22B |
| Scholar Rock Holding | 5.14B |